SCHEMBL2849876

SCHEMBL2849876

CC(C)OC(=O)Oc1cccc2[nH]nnc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.37
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MMP1 P03956 1/20 0.36
MMP2 P08253 1/20 0.36
MMP9 P14780 1/20 0.36
MMP12 P39900 1/20 0.36
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA7 P43166 1/20 0.34
CA9 Q16790 1/20 0.34
CA14 Q9ULX7 1/20 0.34
HSD17B10 Q99714 4/20 0.32
ALDH1A1 P00352 3/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
HPGD P15428 3/20 0.32
MAPT P10636 4/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL44289 0.87 MAPT (0.33) KDM4ELMNAHSD17B10HPGDMAPT
SCHEMBL14690221 0.84 MAPT (0.32) KDM4ELMNAMAPT
Ethylene Glycol SCHEMBL4451270 0.81 MAPT (0.31) LMNAMAPT
SCHEMBL7707716 0.81 SLC22A6 (0.44) KDM4ELMNATP53L3MBTL1HSD17B10
SCHEMBL8844752 0.81 MAPT (0.33) KDM4ELMNAMAPTTDP1
SCHEMBL30442196 0.80 ACHE (0.39) KDM4ELMNATP53L3MBTL1ALDH1A1
SCHEMBL18145367 0.80 ELANE (0.37) LMNAALDH1A1MAPTMEN1KMT2A
SCHEMBL44290 0.79 LMNA (0.35) KDM4ELMNAL3MBTL1CA12CA1
SCHEMBL5526503 0.79 ELANE (0.32)
SCHEMBL9706733 0.79 ADRA1A (0.52) KDM4ELMNATP53L3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210130546-A1 METHODS FOR PREPARING POLYMERIC REAGENTS AND COMPOSITIONS OF POLYMERIC REAGENTS NEKTAR THERAPEUTICS (US) 2021-05-06 US disclosed
US-10421838-B2 Methods for preparing polymeric reagents and compositions of polymeric reagents NEKTAR THERAPEUTICS (US) 2019-09-24 US disclosed
US-20170283552-A1 METHODS FOR PREPARING POLYMERIC REAGENTS AND COMPOSITIONS OF POLYMERIC REAGENTS NEKTAR THERAPEUTICS 2017-10-05 US disclosed
US-9732189-B2 Methods for preparing polymeric reagents and compositions of polymeric reagents NEKTAR THERAPEUTICS (US) 2017-08-15 US disclosed
US-20160289382-A1 METHODS FOR PREPARING POLYMERIC REAGENTS AND COMPOSITIONS OF POLYMERIC REAGENTS NEKTAR THERAPEUTICS 2016-10-06 US disclosed
US-9334364-B2 Methods for preparing polymeric reagents and compositions of polymeric reagents NEKTAR THERAPEUTICS (US) 2016-05-10 US disclosed
EP-1922350-B1 METHODS FOR PREPARING POLYMERIC REAGENTS NEKTAR THERAPEUTICS (US) 2015-01-07 EP disclosed
US-20140323742-A1 METHODS FOR PREPARING POLYMERIC REAGENTS AND COMPOSITIONS OF POLYMERIC REAGENTS NEKTAR THERAPEUTICS 2014-10-30 US disclosed
US-8809489-B2 Methods for preparing polymeric reagents and compositions of polymeric reagents NEKTAR THERAPEUTICS (US) 2014-08-19 US disclosed
US-20130253203-A1 Methods for Preparing Polymeric Reagents and Compositions of Polymeric Reagents NEKTAR THERAPEUTICS (US) 2013-09-26 US disclosed
US-8461295-B2 Methods for preparing polymeric reagents and compositions of polymeric reagents NEKTAR THERAPEUTICS (US) 2013-06-11 US disclosed
US-20120214952-A1 Methods for Preparing Polymeric Reagents and Compositions of Polymeric Reagents NEKTAR THERAPEUTICS (US) 2012-08-23 US disclosed
US-8193306-B2 Methods for preparing polymeric reagents and compositions of polymeric reagents NEKTAR THERAPEUTICS (US) 2012-06-05 US disclosed
US-20100256310-A1 Methods for Preparing Polymeric Reagents and Compositions of Polymeric Reagents NEKTAR THERAPEUTICS (US) 2010-10-07 US disclosed
US-7767784-B2 Active carbonate esters of water-soluble polyoxyethylene glycol NEKTAR THERAPEUTICS (US) 2010-08-03 US disclosed
EP-1922350-A2 METHODS FOR PREPARING POLYMERIC REAGENTS AND COMPOSITIONS OF POLYMERIC REAGENTS Nektar Therapeutics AL, Corporation (US) 2008-05-21 EP disclosed
US-20080064851-A1 Active carbonate esters of water-soluble polyoxyethylene glycol NEKTAR THERAPEUTICS 2008-03-13 US disclosed
WO-2007016560-A9 METHODS FOR PREPARING CARBONATE ESTERS OF POLY(ETYLENE GLYCOL) NEKTAR THERAPEUTICS AL CORP (US) 2007-05-31 WO disclosed
WO-2007016560-A2 METHODS FOR PREPARING CARBONATE ESTERS OF POLY(ETYLENE GLYCOL) NEKTAR THERAPEUTICS AL, CORPORATION (US) 2007-02-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210130546-A1 METHODS FOR PREPARING POLYMERIC REAGENTS AND COMPOSITIONS OF POLYMERIC REAGENTS SI, PHYKPL, PHOSPHO1 KDM4E 1654/4885LMNA 745/4885TP53 1613/4885
US-10421838-B2 Methods for preparing polymeric reagents and compositions of polymeric reagents SI, PHYKPL, PHOSPHO1 KDM4E 1654/4885LMNA 745/4885TP53 1613/4885
US-20130253203-A1 Methods for Preparing Polymeric Reagents and Compositions of Polymeric Reagents SI, PHYKPL, PHOSPHO1 KDM4E 1654/4885LMNA 745/4885TP53 1613/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.